Chlorzoxazone

氯唑沙宗

Report date: 2023/03/14 20:00:30
NME

Base Information

Drug NameChlorzoxazone
Drug Alias Name氯羟苯恶唑clorzoxazonachlorzoxazone氯唑沙腙chlorzoxazonum +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsSoft Tissue InjuriesMusculoskeletal PainMuscle Spasticity +[4] 
Global Approved IndicationsSoft Tissue InjuriesMusculoskeletal PainMuscle Spasticity +[4] 
Approved Indications in ChinaSoft Tissue InjuriesMusculoskeletal PainMuscle Spasticity +[4] 
Original Approved Country/TerritoryCanada
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Shenlong Pharmaceutical Co Ltd
Inactive CompaniesOrtho-Mcneil Pharmaceutical Inc
Active IndicationsSoft Tissue InjuriesMusculoskeletal PainMuscle Spasticity +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeM03BB03
Related LinksWikipediaDrugBankKEGG